Skip to main content

Glipizide

NDC 60760-794 · St. Mary's Medical Park Pharmacy

Generic nameGlipizide
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GLIPIZIDE
Strength5 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

60760-794-30 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-794-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59651-780 — Glipizide, 59651-781 — Glipizide, 59651-782 — Glipizide, 60505-0141 — Glipizide, 60505-0142 — Glipizide, 60687-690 — Glipizide, 60687-701 — Glipizide, 60687-768 — Glipizide, 60687-881 — Glipizide, 60760-793 — Glipizide, 62135-731 — Glipizide and metformin hcl, 62135-732 — Glipizide and metformin hcl, 62135-733 — Glipizide and metformin hcl, 62559-315 — Glipizide, 62559-316 — Glipizide, 63187-811 — Glipizide, 63187-993 — Glipizide, 63629-1398 — Glipizide, 64980-279 — Glipizide, 64980-280 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels